Table 1. Comparison of parameters between PE+ and PE- eyes.
| PE (+) (n = 30) | PE (-) (n = 30) | P value* | |
|---|---|---|---|
| logMAR VA | 0.30 ± 0.59 | 0.07 ± 0.18 | < .0001 |
| Axial length (mm) | 23.88 ± 1.69 | 23.72 ± 1.66 | 0.0009 |
| IOP (mmHg) | 25.5 ± 8.28 | 16.6 ± 3.60 | < .0001 |
| MD (dB) | -15.34 ± 9.06 | -4.01 ± 5.33 | < .0001 |
| vertical C/D ratio | 0.76 ± 0.09 | 0.60 ± 0.08 | < .0001 |
| cpRNFLT (μm) | 62.51 ± 17.7 | 89.55 ± 13.0 | < .0001 |
| mIRT (μm) | 63.92 ± 17.2 | 84.85 ± 13.9 | < .0001 |
| CRAE (μm) | 115.9 ± 10.8 | 125.4 ± 10.5 | < .0001 |
| CRVE (μm) | 171.9 ± 14.5 | 179.5 ± 16.2 | < .0001 |
| ACF (photon counts/msec) | 21.5 ± 29.0 | 9.5 ± 6.07 | < .0001 |
| CECD (cells/mm2) | 2399 ± 205.0 | 2566 ± 246.7 | < .0001 |
| Antiglaucoma medications | 2.32 ± 1.43 | 1.10 ± 1.35 | < .0001 |
PE, pseudoexfoliation material; log MAR VA, logarithm of the minimum angle of resolution visual acuity; IOP, intraocular pressure; MD, visual field mean deviation values; vC/D ratio, vertical cup-to-disc ratio; cpRNFL, circumpapillary retinal nerve fiber layer; mIR, macular inner retinal; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; ACF, anterior chamber flare; CECD, corneal endothelial cell density; Medications, number of antiglaucoma medications use.
*By the Wilcoxon signed-rank test.
Data are expressed as mean±standard deviation.